Celcuity Inc
NASDAQ:CELC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gujarat Ambuja Exports Ltd
NSE:GAEL
|
IN |
During the last 3 months Celcuity Inc insiders have not bought any shares, and sold 2.7m USD worth of shares. The stock price has increased by 5% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/celc/vs/indx/gspc">open performance analysis).
The last transaction was made on Mar 31, 2026 by Buller Richard E , who sold 256k USD worth of CELC shares.
During the last 3 months Celcuity Inc insiders have not bought any shares, and sold 2.7m USD worth of shares. The stock price has increased by 5% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/celc/vs/indx/gspc">open performance analysis).
The last transaction was made on Mar 31, 2026 by Buller Richard E , who sold 256k USD worth of CELC shares.
Celcuity Inc
Glance View
Celcuity, Inc. is cellular analysis company. The company is headquartered in Minneapolis, Minnesota and currently employs 39 full-time employees. The company went IPO on 2017-09-20. The firm is focused on discovering cancer sub-types molecular-based approaches through developing companion diagnostic tests (CDx) and therapeutic (Rx). The firm's product pipeline includes CELsignia platform and Gedatolisib. The CELsignia diagnostic platform is used to analyze live patient tumor cells to identify the specific abnormal cellular process driving a patients cancer and the targeted therapy. The CELsignia platform provides traditional molecular diagnostics, which includes snapshot of the genetic mutations present in a patients tumor because they analyze cell fragments and molecular diagnostics can estimate the patients potential drug response based on a statistical analysis of the drugs clinical trial result. Its other product candidate includes Gedatolisib, is a small molecule dual inhibitor, administered intravenously, that targets all Class I isoforms of PI3K and mammalian target of rapamycin (mTOR).
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.